Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Trial of Two Fixed Doses of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children and Young Adults With Dravet Syndrome

NCT02682927 is registered in ClinicalTrials.gov with Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. as lead sponsor.

NCT NCT02682927
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02682927 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Trial of Two Fixed Doses of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children and Young Adults With Dravet Syndrome
Lead sponsor
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
Phase
Phase 3
Overall status
Completed
Start date
January 15, 2016
Completion date
July 29, 2020
Enrollment
262 (actual)
Sites
55

Conditions

As the registry lists them; a condition with its own page is linked.

dravet syndrome, seizure disorder